Advancing Cancer Genomics: Clinical Oncology NGS Market in North America by 2034
The Clinical Oncology Next Generation Sequencing (NGS) Market is witnessing substantial growth across North America, driven by the increasing adoption of precision medicine, expanding cancer research initiatives, and rising demand for advanced genomic testing solutions. Healthcare providers and research institutions throughout the region are increasingly integrating next generation sequencing...
0 التعليقات 0 المشاركات 101 مشاهدة 0 معاينة